Avant Genomics is a biotechnology company that develops automated laboratory solutions for genomic and cancer research.
Avant Genomics has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
Avant Genomics's investors include Halyard Ventures, TitletownTech, The Global Good Fund, Virginia Venture Partners, CAV Angels.
Avant Genomics is headquartered in Charlottesville, United States.
Avant Genomics is a biotechnology company that develops automated laboratory solutions for genomic and cancer research.
Avant Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avant Genomics — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/avant-genomics. Accessed September 15, 2026.
VCBacked. (2026). Avant Genomics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/avant-genomics
{{cite web |title=Avant Genomics — Funding & Investors |url=https://www.vcbacked.co/company/avant-genomics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated